Skeletal Muscle Myokine Expression in Critical Illness, Association With Outcome and Impact of Therapeutic Interventions
Open Access
- 5 January 2023
- journal article
- research article
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 7 (3), bvad001
- https://doi.org/10.1210/jendso/bvad001
Abstract
Context Muscle expresses and secretes several myokines that bring about benefits in distant organs. Objective We investigated impact of critical illness on muscular expression of irisin, kynurenine-aminotransferases and amylase; association with clinical outcome; and impact of interventions that attenuate muscle wasting/weakness. Design/Setting We studied critically ill patients who participated in two RCTs (EPaNIC/NESCI) and documented time profiles in critically ill mice. Patients/other participants 174 intensive-care-unit (ICU) patients (day 8 ± 1) vs 19 matched controls, 60 mice subjected to surgery/sepsis vs 60 pair-fed healthy mice. Interventions Seven-days neuromuscular electrical stimulation (NMES), withholding parenteral-nutrition in the first ICU-week (late-PN) vs early-PN. Main outcome measures FNDC5 (irisin-precursor), KYAT1, KYAT3 and amylase mRNA-expression in skeletal-muscle. Results Critically ill patients showed a 34-80% lower mRNA-expression of FNDC5, KYAT1 and amylases compared with controls (p < 0.0001). Critically ill mice showed time-dependent reductions in all mRNAs compared with healthy mice (p ≤ 0.04). The lower FNDC5 expression in patients was independently associated with a higher ICU-mortality (p = 0.015) and ICU-acquired weakness (p = 0.012), whereas the lower amylase expression in ICU survivors was independently associated with a longer ICU-stay (p = 0.0060). A lower amylase expression was independently associated with a lower risk of death (p = 0.048) and a lower KYAT1 expression with a lower risk of weakness (p = 0.022). NMES increased FNDC5 expression compared with unstimulated muscle (p = 0.016), and late-PN patients had a higher KYAT1 expression than early-PN patients (p = 0.022). Conclusions Expression of the studied myokines was affected by critical illness and associated with clinical outcomes, with limited effects of interventions that attenuate muscle wasting or weakness.Funding Information
- Methusalem program of the Flemish
- European Research Council Advanced Grants (AdvG-2012-321670, AdvG-2017-785809)
- Research-Foundation Flanders
- Fundamental Clinical Research Fellowship (1700111N, 1805116N)
- university hospitals leuven
This publication has 77 references indexed in Scilit:
- Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophagesCritical Care, 2013
- The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness*Critical Care Medicine, 2012
- Muscle atrophy and preferential loss of myosin in prolonged critically ill patients*Critical Care Medicine, 2012
- Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemiaEuropean Journal of Pharmacology, 2011
- Early versus Late Parenteral Nutrition in Critically Ill AdultsThe New England Journal of Medicine, 2011
- Impact of early parenteral nutrition completing enteral nutrition in adult critically ill patients (EPaNIC trial): a study protocol and statistical analysis plan for a randomized controlled trialTrials, 2011
- Tryptophan degradation and serum neopterin concentrations in intensive care unit patientsToxicology Mechanisms and Methods, 2010
- Dynamics of the Skeletal Muscle Secretome during Myoblast DifferentiationMolecular & Cellular Proteomics, 2010
- Exocrine pancreatic involvement in critically ill patientsCurrent Opinion in Clinical Nutrition and Metabolic Care, 2009
- A prospective observational study of ICU patient position and frequency of turningAnaesthesia, 2008